Fundraising Fox
/Companies
Sign in

Katalysen

also invests · investor profile

Stockholm, SE · Founded 2016 · 17 employees on LinkedIn · 1 known investors

Find your way into Katalysen

Each arrow is one introduction. Sign up to fill in the first one.

98 people can intro you to Anders

Ask Emil Ahlanzberg to introduce you to Anders Dahlgren

You →Emil · together at Katalysen →Anders

11 people can intro you to Peter

Ask Jamie Chen to introduce you to Peter Almberg

You →Jamie · together at Katalysen →Peter

Sign up to find every way you can get introduced to Katalysen

  • Your email: who you already know at Katalysen, and who your contacts know
  • 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Katalysen team
  • Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

Sign up with GoogleAlready have an account? Log in

QuTEM provides electron microscopy analytics with proprietary software (Gridsee) for quality control of gene therapies, enabling manufacturers to ensure safety and consistency at regulatory and production scale. The company serves pharmaceutical and gene therapy manufacturers navigating commercialization and regulatory approval requirements.

BiotechDeep TechEnterprise SoftwareFintechMedical DevicesSector Agnostic

Founders & leadership

Katalysen was founded in 2016 by Peter Almberg.

PAPeter Almberg
Peter AlmbergWorking ChairmanPeter Almberg has spent over four decades in venture building and financial innovation, founding and leading fintech companies including Utvecklings AB Servisen (acquired by Fidelity Information Services) and Servisen Optimating AB, and serving as CEO of a small-cap stock exchange. He is working chairman of Katalysen Ventures, a publicly traded company focused on identifying and solving complex, large-scale problems through venture partnerships.
ADAnders Dahlgren
Anders DahlgrenCEOCEO at Katalysen Ventures

Investors · 1

In the news

Katalysen Ventures Announces Strategic Initiative to Broaden Shareholder Base and Strengthen Investor Relations — Katalysen IRkatalysen.com · Nov 2025

Frequently asked questions

What does Katalysen do?
QuTEM provides electron microscopy analytics with proprietary software (Gridsee) for quality control of gene therapies, enabling manufacturers to ensure safety and consistency at regulatory and production scale. The company serves pharmaceutical and gene therapy manufacturers navigating commercialization and regulatory approval requirements.
Who founded Katalysen?
Katalysen was founded by Peter Almberg in 2016.
Who are Katalysen's investors?
Katalysen's investors include Kuorrokveik Adventure Capital.
Where is Katalysen headquartered?
Katalysen is headquartered in Stockholm, SE.